# Combination of Chemotherapy and Gefitinib as First-line Treatment

> **NCT02148380** · NA · COMPLETED · sponsor: **Baohui Han** · enrollment: 121 (actual)

## Conditions studied

- Non-Small-Cell Lung Cancer

## Interventions

- **DRUG:** pemetrexed plus carboplatin
- **DRUG:** gefitinib

## Key facts

- **NCT ID:** NCT02148380
- **Lead sponsor:** Baohui Han
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02148380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02148380, "Combination of Chemotherapy and Gefitinib as First-line Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02148380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*